Left Atrial Appendage Occlusion: A Narrative Review.

Area of Science:

• Cardiology
• Medical Devices
• Interventional Procedures

Background:

• Atrial fibrillation (AF) poses a significant stroke risk, often managed with oral anticoagulation.
• Left atrial appendage occlusion (LAAO) is an emerging alternative to oral anticoagulation, particularly for patients with contraindications or high bleeding risk.
• The definitive safety and efficacy of LAAO compared to established treatments remain subjects of active research.

Purpose of the Study:

• To review the current evidence on percutaneous and surgical Left Atrial Appendage Occlusion (LAAO) devices.
• To examine existing clinical guidelines pertaining to LAAO procedures.
• To summarize key findings from landmark clinical trials evaluating LAAO.

Main Methods:

• Narrative review of existing literature on LAAO devices.
• Analysis of current clinical practice guidelines for LAAO.
• Synthesis of data from significant randomized controlled trials and observational studies.

Main Results:

• Evidence on percutaneous and surgical LAAO devices is accumulating, with ongoing trials comparing different devices and anticoagulation therapies.
• Current guidelines provide recommendations for LAAO in specific patient populations, though uncertainties persist.
• Landmark trials are crucial for establishing the relative safety and efficacy of LAAO.

Conclusions:

• Left atrial appendage occlusion (LAAO) is a promising alternative for stroke prevention in atrial fibrillation patients.
• Further evidence from ongoing randomized trials is necessary to definitively establish the safety and efficacy of LAAO.
• LAAO is particularly considered for patients at high risk of stroke or bleeding, or those with contraindications to anticoagulation.